Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity
- 31 March 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 103 (3), 427-435
- https://doi.org/10.1016/s0091-6749(99)70467-7
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Comparison of Regularly Scheduled with As-Needed Use of Albuterol in Mild AsthmaNew England Journal of Medicine, 1996
- Inhaled β2-Agonists in the Treatment of AsthmaNew England Journal of Medicine, 1996
- Asthma and the beta agonist debate.Thorax, 1995
- Regular vs as-needed inhaled salbutamol in asthma controlThe Lancet, 1994
- Guidelines for the management of asthma: a summary. British Thoracic Society and others.BMJ, 1993
- The Use of β-Agonists and the Risk of Death and near Death from AsthmaNew England Journal of Medicine, 1992
- Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study.BMJ, 1991
- Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthmaJournal of Allergy and Clinical Immunology, 1987
- Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: A comparison between budesonide and terbutalineJournal of Allergy and Clinical Immunology, 1985
- Reproducibility and comparison of responses to inhaled histamine and methacholine.Thorax, 1978